Literature DB >> 8616818

Simultaneous expression of cadherin-11 in signet-ring cell carcinoma and stromal cells of diffuse-type gastric cancer.

T Shibata1, A Ochiai, M Gotoh, R Machinami, S Hirohashi.   

Abstract

We examined the expression of cadherin-11, a type II cadherin, in normal human tissues, cell lines and gastric cancer surgical specimens. Cadherin-11 was expressed widely in adult tissues, except the liver. It was expressed in fibroblast, mesothelial cell lines, and in only two signet ring cell carcinomas out of 16 various cancer cell lines. Cadherin-11 expression was detected in both signet ring cell carcinoma cells and surrounding fibroblasts of surgical specimens by in situ hybridization. These results suggest that cadherin-11 may play a role in the formation of diffuse-type gastric cancer through cancer-stromal interactions.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8616818     DOI: 10.1016/0304-3835(95)04047-1

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  18 in total

1.  Myofibroblast development is characterized by specific cell-cell adherens junctions.

Authors:  B Hinz; P Pittet; J Smith-Clerc; C Chaponnier; J-J Meister
Journal:  Mol Biol Cell       Date:  2004-07-07       Impact factor: 4.138

2.  Cadherin-11, a marker of the mesenchymal phenotype, regulates glioblastoma cell migration and survival in vivo.

Authors:  Harpreet Kaur; Polly J Phillips-Mason; Susan M Burden-Gulley; Amber E Kerstetter-Fogle; James P Basilion; Andrew E Sloan; Susann M Brady-Kalnay
Journal:  Mol Cancer Res       Date:  2012-01-20       Impact factor: 5.852

3.  Cadherin-11 increases migration and invasion of prostate cancer cells and enhances their interaction with osteoblasts.

Authors:  Chih-Fen Huang; Cristina Lira; Khoi Chu; Mehmet Asim Bilen; Yu-Chen Lee; Xiangcang Ye; Soo Mi Kim; Angelica Ortiz; Fe-Lin Lin Wu; Christopher J Logothetis; Li-Yuan Yu-Lee; Sue-Hwa Lin
Journal:  Cancer Res       Date:  2010-05-18       Impact factor: 12.701

4.  Identification of cadherin 11 as a mediator of dermal fibrosis and possible role in systemic sclerosis.

Authors:  Minghua Wu; Mesias Pedroza; Robert Lafyatis; Anuh-Teresa George; Maureen D Mayes; Shervin Assassi; Filemon K Tan; Michael B Brenner; Sandeep K Agarwal
Journal:  Arthritis Rheumatol       Date:  2014-04       Impact factor: 10.995

5.  Dominant-negative E-cadherin inhibits the invasiveness of inflammatory breast cancer cells in vitro.

Authors:  Hui-Ming Dong; Gang Liu; Yi-Feng Hou; Jiong Wu; Jin-Song Lu; Jian-Min Luo; Zhen-Zhou Shen; Zhi-Ming Shao
Journal:  J Cancer Res Clin Oncol       Date:  2006-08-24       Impact factor: 4.553

6.  Cadherin-11 expression patterns in heart valves associate with key functions during embryonic cushion formation, valve maturation and calcification.

Authors:  Jingjing Zhou; Caitlin Bowen; Gloria Lu; Calvin Knapp Iii; Andrew Recknagel; Russell A Norris; Jonathan T Butcher
Journal:  Cells Tissues Organs       Date:  2013-12-20       Impact factor: 2.481

7.  MicroRNA-145 suppresses cell invasion and metastasis by directly targeting mucin 1.

Authors:  Mohit Sachdeva; Yin-Yuan Mo
Journal:  Cancer Res       Date:  2009-12-08       Impact factor: 12.701

8.  Anomalous cadherin expression in osteosarcoma. Possible relationships to metastasis and morphogenesis.

Authors:  T Kashima; J Kawaguchi; S Takeshita; M Kuroda; M Takanashi; H Horiuchi; T Imamura; Y Ishikawa; T Ishida; S Mori; R Machinami; A Kudo
Journal:  Am J Pathol       Date:  1999-11       Impact factor: 4.307

9.  Cadherin-11 regulates fibroblast inflammation.

Authors:  Sook Kyung Chang; Erika H Noss; Mei Chen; Zhizhan Gu; Kirk Townsend; Rosa Grenha; Luis Leon; Soo Young Lee; David M Lee; Michael B Brenner
Journal:  Proc Natl Acad Sci U S A       Date:  2011-05-02       Impact factor: 11.205

10.  Development of a method to isolate circulating tumor cells using mesenchymal-based capture.

Authors:  Rhonda L Bitting; Rengasamy Boominathan; Chandra Rao; Gabor Kemeny; Brad Foulk; Mariano A Garcia-Blanco; Mark Connelly; Andrew J Armstrong
Journal:  Methods       Date:  2013-07-09       Impact factor: 3.608

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.